PALATIN TECHNOLOGIES, INC. Finance Lease, Liability, Current
PALATIN TECHNOLOGIES, INC. (PTN) had Finance Lease, Liability, Current of $0 as of 2025-06-30, per its 10-K filed 2025-09-23.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:FinanceLeaseLiabilityCurrent · last filed 2025-09-23
- 2025-06-30: Finance Lease, Liability, Current $0.00.
- 2025-03-31: Finance Lease, Liability, Current $0.00.
- 2024-12-31: Finance Lease, Liability, Current $0.00.
- 2024-09-30: Finance Lease, Liability, Current $18.53K.
| Period end | Finance Lease, Liability, Current |
|---|---|
| 2025-06-30 | $0.00 10-K · filed 2025-09-23 |
| 2025-03-31 | $0.00 10-Q · filed 2025-05-14 |
| 2024-12-31 | $0.00 10-Q · filed 2025-02-13 |
| 2024-09-30 | $18.53K 10-Q · filed 2024-11-14 |
| 2024-06-30 | $46.01K 10-K · filed 2025-09-23 |
| 2024-03-31 | $73.14K 10-Q · filed 2024-05-15 |
| 2023-12-31 | $99.91K 10-Q · filed 2024-02-14 |
| 2023-09-30 | $107.81K 10-Q · filed 2023-11-14 |
| 2023-06-30 | $106.39K 10-K · filed 2024-09-30 |
| 2023-03-31 | $105.00K 10-Q · filed 2023-05-15 |
| 2022-12-31 | $103.62K 10-Q · filed 2023-02-14 |
| 2022-09-30 | $102.26K 10-Q · filed 2022-11-14 |
| 2022-06-30 | $100.92K 10-K · filed 2023-09-28 |
| 2022-03-31 | $99.60K 10-Q · filed 2022-05-16 |
| 2021-06-30 | $0.00 10-K · filed 2022-09-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B |